Diabetes 54:2041-2052, 2005
© 2005 by the American Diabetes Association, Inc.
Immune Cell Infiltration, Cytokine Expression, and ß-Cell Apoptosis During the Development of Type 1 Diabetes in the Spontaneously Diabetic LEW.1AR1/Ztm-iddm Rat
Anne Jörns1,2,
Armin Günther1,
Hans-Jürgen Hedrich3,
Dirk Wedekind3,
Markus Tiedge2, and
Sigurd Lenzen2
1 Centre of Anatomy, Hannover Medical School, Hannover, Germany
2 Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany
3 Institute of Laboratory Animal Science, Hannover Medical School, Hannover, Germany
The IDDM (LEW.1AR1/Ztm-iddm) rat is a type 1 diabetic animal model characterized by a rapid apoptotic pancreatic ß-cell destruction. Here we have analyzed the time course of islet infiltration, changes in the cytokine expression pattern, and ß-cell apoptosis in the transition from the pre-diabetic to the diabetic state. Transition from normoglycemia to hyperglycemia occurred when ß-cell loss exceeded 60–70%. At the early stages of islet infiltration, macrophages were the predominant immune cell type in the peripherally infiltrated islets. Progression of ß-cell loss was closely linked to a severe infiltration of the whole islet by CD8+ T-cells. With progressive islet infiltration, interleukin-1ß (IL-1ß) and tumor necrosis factor- (TNF- ) were expressed in immune cells but not in ß-cells. This proinflammatory cytokine expression pattern coincided with the expression of inducible nitric oxide synthase (iNOS) and procaspase 3 in ß-cells and a peak apoptosis rate of 6.7%. Islet infiltration declined after manifestation of clinical diabetes, yielding end-stage islets devoid of ß-cells and immune cells without any sign of cytokine expression. The observed coincidence of IL-1ß and TNF- expression in the immune cells and the induction of iNOS and procaspase 3 mRNA expression in the ß-cells depicts a sequence of pathological changes leading to apoptotic ß-cell death in the IDDM rat. This chain of events provides a mechanistic explanation for the development of the diabetic syndrome in this animal model of human type 1 diabetes.
Address correspondence and reprint requests to Dr. Sigurd Lenzen, Institute of Clinical Biochemistry, Hannover Medical School, D-30623 Hannover, Germany. lenzen.sigurd{at}mh-hannover.de
Abbreviations:
IL-1ß, interleukin-1ß;; IFN- , interferon- ;; iNOS, inducible nitric oxide synthase;; TNF- , tumor necrosis factor- ;; TUNEL, TdT-mediated dUTP-biotin nick-end labeling

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. C. Kaizer, C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White
Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes
J. Clin. Endocrinol. Metab.,
September 1, 2007;
92(9):
3705 - 3711.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
| |
|